Diabetes Complications
Conditions or pathological processes associated with the disease of diabetes mellitus. Due to the impaired control of BLOOD GLUCOSE level in diabetic patients, pathological processes develop in numerous tissues and organs including the EYE, the KIDNEY, the BLOOD VESSELS, and the NERVE TISSUE.
Subtype terms (8)
More specific conditions that are subtypes of Diabetes Complications in the MeSH hierarchy.
- Diabesity
- Diabetic Angiopathies
9 drugs (6 approved, 3 experimental)
- Diabetic Cardiomyopathies
7 drugs (2 approved, 5 experimental)
- Diabetic Coma
- Diabetic Ketoacidosis
15 drugs (12 approved, 3 experimental)
- Diabetic Nephropathies
197 drugs (98 approved, 99 experimental)
- Diabetic Neuropathies
136 drugs (68 approved, 68 experimental)
- Fetal Macrosomia
4 drugs approved
Drugs by status
Phase 4 trials (9)
Phase 3 trials (5)
Phase 2 trials (13)
Phase 1 trials (4)
Organizations
Organization Involved with Phase 4 Indications (6)
Organization Involved with Phase 3 Indications (4)
Organization Involved with Phase 2 Indications (17)
- Amylin
- Eli Lilly
- Grifols
- Pfizer
- Han Wha Pharma Co., Ltd.
- Motus Therapeutics, Inc.
- Rhythm Pharmaceuticals, Inc.
- Quark Pharmaceuticals
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Harvard University
- Seoul National University
- University of California, Davis
- University of Colorado, Denver
- University of Campinas
- University of Colorado
- ANS Pharma
- Goldfinch Bio, Inc.
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (12)
- National Institutes of Health (NIH)
- National Heart, Lung, and Blood Institute (NHLBI)
- Federal University of Rio Grande do Sul
- Institute for Atherosclerosis Research, Russia
- Loma Linda University
- University of Avignon
- University of Bern
- Tel Aviv University
- Catholic University of Korea
- Washington University in St. Louis
- Leducq Foundation
- Velux Fonden